Clinical Trial Results:
Randomized, Double-Blind, Active-Controlled Trial to Assess the Safety and Immunogenicity of Solvay's Cell-Derived Influenza Vaccine, Including Revaccination, in Elderly subjects.
Summary
|
|
EudraCT number |
2009-014767-40 |
Trial protocol |
CZ EE LT |
Global completion date |
28 Apr 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Aug 2019
|
First version publication date |
07 Aug 2019
|
Other versions |
|
Summary report(s) |
S203.2.009-Synopsis-Year 1_no redaction marks S203.2.009-Synopsis-Year 2_no redaction marks |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.